Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18405987rdf:typepubmed:Citationlld:pubmed
pubmed-article:18405987lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:18405987lifeskim:mentionsumls-concept:C0012242lld:lifeskim
pubmed-article:18405987lifeskim:mentionsumls-concept:C1518578lld:lifeskim
pubmed-article:18405987lifeskim:mentionsumls-concept:C0152018lld:lifeskim
pubmed-article:18405987lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:18405987lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:18405987lifeskim:mentionsumls-concept:C0246415lld:lifeskim
pubmed-article:18405987lifeskim:mentionsumls-concept:C0920321lld:lifeskim
pubmed-article:18405987lifeskim:mentionsumls-concept:C0443196lld:lifeskim
pubmed-article:18405987lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:18405987pubmed:issue3lld:pubmed
pubmed-article:18405987pubmed:dateCreated2008-6-18lld:pubmed
pubmed-article:18405987pubmed:abstractTextA dose-escalation study of docetaxel combined with cisplatin, 5-fluorouracil, and concurrent radiotherapy (DCF-R) was performed to determine the optimal dose in patients with advanced esophageal carcinoma.lld:pubmed
pubmed-article:18405987pubmed:languageenglld:pubmed
pubmed-article:18405987pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405987pubmed:citationSubsetIMlld:pubmed
pubmed-article:18405987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405987pubmed:statusMEDLINElld:pubmed
pubmed-article:18405987pubmed:monthJunlld:pubmed
pubmed-article:18405987pubmed:issn0167-8140lld:pubmed
pubmed-article:18405987pubmed:authorpubmed-author:HayakawaKazus...lld:pubmed
pubmed-article:18405987pubmed:authorpubmed-author:KoizumiWasabu...lld:pubmed
pubmed-article:18405987pubmed:authorpubmed-author:TanabeSatoshi...lld:pubmed
pubmed-article:18405987pubmed:authorpubmed-author:SasakiTohruTlld:pubmed
pubmed-article:18405987pubmed:authorpubmed-author:KatadaChikato...lld:pubmed
pubmed-article:18405987pubmed:authorpubmed-author:HiguchiKatsuh...lld:pubmed
pubmed-article:18405987pubmed:authorpubmed-author:IshiyamaHirom...lld:pubmed
pubmed-article:18405987pubmed:issnTypePrintlld:pubmed
pubmed-article:18405987pubmed:volume87lld:pubmed
pubmed-article:18405987pubmed:ownerNLMlld:pubmed
pubmed-article:18405987pubmed:authorsCompleteYlld:pubmed
pubmed-article:18405987pubmed:pagination398-404lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:meshHeadingpubmed-meshheading:18405987...lld:pubmed
pubmed-article:18405987pubmed:year2008lld:pubmed
pubmed-article:18405987pubmed:articleTitleA phase I trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma: Kitasato digestive disease & oncology group trial (KDOG 0501).lld:pubmed
pubmed-article:18405987pubmed:affiliationDepartment of Gastroenterology, and Kitasato University School of Medicine, Kanagawa, Japan. k.higu@kitasato-u.ac.jplld:pubmed
pubmed-article:18405987pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18405987pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18405987lld:pubmed